This list is an analysis based on recent market events. It's not an investment recommendation.
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.
FAQs
What is Nasus Pharma stock price today?▼
The current price of NSRX.BOATS is $2.95 USD — it has increased by +0% in the past 24 hours. Watch Nasus Pharma stock price performance more closely on the chart.
What is Nasus Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Nasus Pharma stocks are traded under the ticker NSRX.BOATS.
What is Nasus Pharma market cap?▼
Today Nasus Pharma has the market capitalization of 34.56M
When is the next Nasus Pharma earnings date?▼
Nasus Pharma is going to release the next earnings report on March 3, 2027.
What were Nasus Pharma earnings last quarter?▼
NSRX.BOATS earnings for the last quarter are -0.54 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
In which sector is Nasus Pharma located?▼
Nasus Pharma operates in the Other sector.
When did Nasus Pharma complete a stock split?▼
Nasus Pharma has not had any recent stock splits.